11Apr/14

Sovaldi Continues to Excel in Trials with Hep C, Advanced Liver Disease – Drug Discovery & Development


Drug Discovery & Development

Sovaldi Continues to Excel in Trials with Hep C, Advanced Liver Disease
Drug Discovery & Development
Study GS-US-334-0126 was a single-arm open-label Phase 2 trial in which patients with established recurrent HCV infection following liver transplantation received up to 24 weeks of therapy with Sovaldi plus RBV (escalating doses starting at 400 mg/day).
New data reveals positive outcomes for hepatitis C transplant patientsEureka! Science News

all 51 news articles »

11Apr/14

Blood donation initiative to address shortage – Capital FM Kenya


Capital FM Kenya

Blood donation initiative to address shortage
Capital FM Kenya
NAIROBI, Kenya, Apr 11 – The Kenya National Blood Transfusion Service (KNBTS) on Friday announced a countrywide Easter special blood donation initiative that is set to begin from April 12 to April 30. KNBTS National Director Margaret Oduor said through …
Blood Donation Drive Set For Easter PeriodCitizen News

all 4 news articles »